| NewsClick

For latest updates on COVID-19 around the world visit our INTERACTIVE COVID MAP

Newsclick Report
India Has Fewer Researchers Than China and South Korea, Says Report
29 Nov 2019
According to the report, India is falling way behind other countries in terms of funds devoted to research and development.
Newsclick Production
Compulsory License for Medicines: Government Protecting the Interest of India or the US?
28 Mar 2016
In order to ensure that drug companies cannot play with the lives of patients (for instance by either stopping the sale of a drug or making it incredibly expensive) - the Indian Patents Act…
Author
India-US Joint Working Group on IPR
05 Nov 2014
21 October 2014
Amit Sengupta
Capitulation on IP: Reaching a Point of No Return?
27 Oct 2014
The government has chosen the occasion of Prime Minister Modi’s visit to the US to articulate a vision on Intellectual Property (IP) protection that promises to radically reshape the Indian IP system…
Prabir Purkayastha
Modi's US Visit: Introducing Bad Patents and Removing Liability for US Suppliers
09 Oct 2014
The US-India Joint Statement signed during Modi's visit to the US has opened the doors for two Indian laws that have been passed by the Indian Parliament. One is on patents – the Indian Patents Act…
Amit Sengupta
South African Patients Need our Solidarity
23 Jan 2014
A few days back, the Health Minister of South Africa, Dr Motsoaledi, characterised an elaborate plot hatched by large multinational drug companies as "genocide" and a conspiracy of "satanic magnitude…
Newsclick Production
US Supreme Court Strikes Down Natural Gene Patents
29 Jun 2013
Newsclick discusses with Dr. Satyajit Rath from the National Institute of Immunology the US Supreme Court's ruling on gene patenting. The judgement comes in two parts. One, natural genes cannot be…
Newsclick Production
Motivated Campaign To Kill Generic Industry
15 Jun 2013
In the backdrop of the Ranbaxy case in the US, Newsclick talks to Dr Amit Sengupta from the Jan Swasthya Abhyan on the situation in the pharmaceutical sector at large. Dr Sengupta says that a…
Prabir Purkayastha
Novartis Case, Innovation and Patents
23 Apr 2013
The Supreme Court's judgement throwing out Novartis’ attempts to secure a patent for the leukaemia drug Glivec has created a frenzy in the pink press – both in India and abroad.
Newsclick Production
Open Source Biology: An Interview with Dr. Richard Jefferson
28 Aug 2010
The big multinational biotech companies can grant or deny the legal use of biological information due to which independent research organizations usually suffer. Patent restriction debate has…